Jonathan C. Cheng, Ph.D.
Affiliations: | 2003 | University of Southern California, Los Angeles, CA, United States |
Area:
DNA methylation, cancer, epigeneticsGoogle:
"Jonathan Cheng"Mean distance: 14248.8
Parents
Sign in to add mentorPeter A. Jones | grad student | 2003 | USC | |
(Characterization of zebularine: A novel inhibitor of DNA methylation with clinical potential.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cheng JC, Chiang MT, Lee CH, et al. (2015) γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Journal of Dental Research |
Gupta S, O'Donnell P, Plimack ER, et al. (2015) MP68-11 A PHASE 1B STUDY OF PEMBROLIZUMAB (PEMBRO; MK-3475) FOR ADVANCED UROTHELIAL CANCER Journal of Urology. 193 |
Lai ZL, Tsou YA, Fan SR, et al. (2014) Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma. Biomed Research International. 2014: 378358 |
Marquez VE, Kelley JA, Agbaria R, et al. (2005) Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Annals of the New York Academy of Sciences. 1058: 246-54 |
Marquez VE, Barchi JJ, Kelley JA, et al. (2005) Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology. Nucleosides, Nucleotides & Nucleic Acids. 24: 305-18 |
Friedrich MG, Chandrasoma S, Siegmund KD, et al. (2005) Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. European Journal of Cancer (Oxford, England : 1990). 41: 2769-78 |
Friedrich MG, Weisenberger DJ, Cheng JC, et al. (2004) Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7457-65 |
Yoo CB, Cheng JC, Jones PA. (2004) Zebularine: a new drug for epigenetic therapy. Biochemical Society Transactions. 32: 910-2 |
Cheng JC, Yoo CB, Weisenberger DJ, et al. (2004) Preferential response of cancer cells to zebularine. Cancer Cell. 6: 151-8 |
Liang G, Lin JC, Wei V, et al. (2004) Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proceedings of the National Academy of Sciences of the United States of America. 101: 7357-62 |